Skip to content

Clinical trials

Phase 3 Papillomavirus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Papillomavirus Infections Phase: Phase 3 Clear all

95 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20045
20054
20065
200711
20086
200912
20101
201111
20122
20132
20142
20153
20171
20181
20193
20203
20216
20226
20233
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Active, not recruiting11
Unknown status7
Not yet recruiting4
Withdrawn3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline41
Merck Sharp & Dohme LLC26
Beijing Health Guard Biotechnology, Inc3
Shanghai Bovax Biotechnology Co., Ltd.3
AIDS Malignancy Consortium2
International Agency for Research on Cancer2
National Vaccine and Serum Institute, China2
Shanghai Zerun Biotechnology Co.,Ltd2
Assiut University1
CHU de Quebec-Universite Laval1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Papillomavirus Infections95
Uterine Cervical Neoplasms30
Condylomata Acuminata10
Vaginal Neoplasms9
Vulvar Neoplasms8
HIV Infections5
Infections4
Uterine Cervical Dysplasia4
Anus Neoplasms3
Meningitis2

Trials

Showing 76 to 95 of 95. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.